Record Q3 financial performance with revenue reaching $1.8B (+12.6% YoY) and Adjusted EBITDA of $660M (+16.2% YoY), indicating strong operational execution and market demand Significant shareholder return enhancement through 10% dividend increase to $0.864 per share, signaling management's confidence in sustainable cash flow generation and AFFO growth trajectory Positive business momentum…

Our analysis rates this filing BULLISH. This filing represents an exceptionally strong quarterly performance with no material concerns. The company achieved record results across all key financial metrics with clear margin expansion (EBITDA +16.2% vs Revenue +12.6%). The 10% dividend increase is a…

Concern level: LOW (1.5/10).

Notable risk changes: Strong Q3 2025 performance with record revenue of $1.8B (up 12.6% YoY) and record Adjusted EBITDA of $660M (up 16.2% YoY); 10% dividend increase to $0.864 per share reflecting confidence in continued AFFO growth and strong financial performance; Reaffirmed full year 2025 guidance with Q4 expected to show ~14% revenue and Adjusted EBITDA growth, demonstrating business momentum.

The model predicts IRM will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.